Orthofix launches new bioactive synthetic graft
Orthofix earned FDA 510(k) clearance for its OsteoCove advance bioactive synthetic graft, the company said Oct. 12.
Stay updated with breaking news from Tyler Lipschultz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Orthofix earned FDA 510(k) clearance for its OsteoCove advance bioactive synthetic graft, the company said Oct. 12.
12.10.2023 - Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the 510k clearance and full commercial launch of OsteoCove, an advanced bioactive synthetic graft. Available in both a putty and strip ... Seite 1
Orthofix and SeaSpine today completed its previously announced merger of equals to create a global spine and orthopedics company.
CARLSBAD, Calif., May 02, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical...